CrushSCI.com
Journal Selection & Manuscript Polishing Services
Current Research in Translational Medicine journal cover Medicine
Back to journal directory

Review Cycle Records

Current Research in Translational Medicine

Elsevier SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q2
156.5Average days
151.5Median days
80Fastest days
285Longest days
712025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

184 days

Impact of bone marrow fibrosis on disease characteristics and outcomes in newly diagnosed multiple myeloma patients

AuthorsAli Ahadzade; Tugrul Elverdi; Selin Kucukyurt; Abdulkadir Ercaliskan; Tuba Ozkan; Ahu Senem Demiröz; Deniz Ozmen; Umut Yılmaz; Ahmet Emre Eskazan; Muhlis Cem Ar; Yıldız Aydın; Ayse Salihoglu

AffiliationsDivision of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey; Department of Pathology, Cerrahpaşa Faculty of Medicine, İstanbul University-Cerrahpaşa, İstanbul, Turkey

Source PDF DOI Publisher page
118 days

Non-invasive differentiation between aplastic anemia and myelodysplastic syndromes based on an 8-feature lightGBM model: A multicenter external validation study

AuthorsSumei Wang; Zihan Cai; Wei Wei; Shoudong Zhang; Sha Chen; Yurong Zhang

AffiliationsDepartment of Hematology, Siyang Hospital, Siyang 223700, China; Department of Medical Laboratory, Siyang Hospital, Siyang 223700, China

Source PDF DOI Publisher page
111 days

Allogeneic mesenchymal stem cell therapy combined with photobiomodulation for neonatal soft-tissue necrosis: A case report

AuthorsThais de Andrade Farias Rodrigues; Edilene Villalba dos Santos; Marina Juliana Pita Sassioto Silveira de Figueiredo; Patricia Guenka Scarcelli; Lorena de Paula Silva; Silvia Cordeiro das Neves; Valeriane Maia Siravegna; Rodrigo Juliano Oliveira

AffiliationsCentro de Estudos em Células-Tronco, Terapia Celular e Genética Toxicológica, Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil; Centro de Processamento Celular, Hospital Universitário Maria Aparecida Pedrossian, Campo Grande, MS, Brazil; Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil; Department of Pediatrics, Hospital Universitário Maria Aparecida Pedrossian, Campo Grande, MS, Brazil

Source PDF DOI Publisher page
176 days

Detection of acute lymphocytic and myeloid leukaemia with optimized dimensionality reduction and deep learning classification framework

AuthorsMohamudha Parveen Rahamathulla; Shtwai Alsubai; Mohemmed Sha

AffiliationsSchool of Life and Health Sciences, University of Roehampton, London, United Kingdom; Department of Computer Science, College of Computer Engineering and Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia; School of Computing, Engineering and the Built Environment, Roehampton University, London, United Kingdom

Source PDF DOI Publisher page
285 days

Comparison of genomic response among patients receiving dendritic cell vaccines pulsed with two different cancer-associated antigens: A retrospective observational study

AuthorsKhin Zay Yar Myint; Masamori Shimabuku; Yoko Shimizu; Junichi Taguchi

AffiliationsCentre for Advanced Medical Science and Technology, Tokyo Midtown Medical Centre, Tokyo, Japan

Source PDF DOI Publisher page
80 days

A fault tree analysis of early treatment failure in Acute myeloid leukemia

AuthorsMobina Shrestha; Salina Dahal; Vishal Mandal

AffiliationsSentara Albemarle Medical Center, Elizabeth City, NC 27909, USA; The Ohio State University, Columbus, OH 43210, USA; University of Missouri Columbia, Columbia, MO 65211, USA

Source PDF DOI Publisher page
203 days

Donor demographics and leukopak consistency: Yield and composition as operational benchmarks for cell-therapy starting materials

AuthorsIrene Gómez-Gràcia; Daniel Gonnermann; Lisa Paschold; Albert Castey; Julia Marie Schäfer; Katharina Renate Winterstein; Anke Wahler; Doris Gloger; Liane Klinke; Barbara Ingrid Baumann-Baretti; Francisco Javier Belda

AffiliationsGrifols, Bio Supplies, Research and Development Department, Barcelona, Spain; Haema Bio Supplies Division, Haema GmbH, Leipzig, Germany

Source PDF DOI Publisher page
137 days

Efficacy of bispecific T-cell engagers after CAR T-cell therapy failure in aggressive large B-cell lymphoma

AuthorsMohamed A. Kharfan-Dabaja; Tea Reljic; Sarah Abdel-Razeq; Zaid Sarhan; Razan Mohty; Katelyn Keller; Madiha Iqbal; Julio C. Chavez; Yan Luo; Hong Qin; Mahmoud Aljurf; Ambuj Kumar

AffiliationsDivision of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy program, Mayo Clinic, Jacksonville, FL, USA; Research Methodology and Biostatistics Core, Office of Research, Morsani College of Medicine, University of South Florida, Tampa, FL, USA; University of Jordan, Amman, Jordan; Department of Internal Medicine, Ministry of Health, Amman, Jordan; Division of Hematology-Oncology and O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA; Adult Hematology, Stem Cell Transplant and Cellular Therapy Section, Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Source PDF DOI Publisher page
105 days

Generalized skeletal sclerosis as a potential late effect of total body irradiation after allogeneic hematopoietic stem cell transplantation: A case report

AuthorsBakoubassé Aïssata Son; Lucie Lemeunier; Yazid Belkacemi; Remy Dulery; Mohamad Mohty; Mickaël Rousière; Lise Minssen; Jean-Denis Laredo; Francis Berenbaum; Sabryne Berkani; Alice Courties

AffiliationsRheumatology Department, Bogodogo University Hospital Center, Ouagadougou, Burkina Faso; AP-HP Saint-Antoine Hospital, Rheumatology Department, Sorbonne University, Saint-Antoine Research Center (CRSA), Inserm 938, 75012 Paris, France; AP-HP GHU Henri Mondor, Department of radiation Oncology, University of Paris East Creteil (UPEC). INSERM 955 i-Biot Unit., Creteil, France; Sorbonne University, Clinical Hematology and Cellular Therapy Department, Saint-Antoine Hospital, AP-HP, Paris, France; Radiology Department, Saint-Antoine Hospital, 75012 Paris, France; Université Paris-Cité, Paris, France

Source PDF DOI Publisher page
166 days

Impact of the rest period between sequential chemotherapy and conditioning regimen prior to allogeneic hematopoietic stem cell transplantation for high-risk myeloid malignancies

AuthorsValentin Amenta; Anne Sonet; Elodie Collinge; François Dachy; Cristina Baiana; Benoît Bihin; Xavier Poiré; Carlos Graux

AffiliationsUniversité catholique de Louvain (UCLouvain), department of Hematology, CHU UCL Namur – Godinne, Yvoir, Belgium; Research Fellow of the Fonds de la Recherche Scientifique – FNRS, Belgium; Université catholique de Louvain (UCLouvain), Scientific Support Unit, CHU UCL Namur – Godinne, Yvoir, Belgium; Université de Namur (UNamur), Namur, Belgium; Université catholique de Louvain (UCLouvain), department of Hematology, Cliniques universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.